Galanin-1-16

[1]  T. Bártfai,et al.  Novel galanin receptor ligands. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[2]  R. Sankar,et al.  Galanin – 25 years with a multitalented neuropeptide , 2008, Cellular and Molecular Life Sciences.

[3]  B. Kofler,et al.  The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. , 2007, Pharmacology & therapeutics.

[4]  T. Land,et al.  Galanin receptor subtypes and ligand binding , 2000, Neuropeptides.

[5]  M. Bayne,et al.  Cloning and Expressional Characterization of a Novel Galanin Receptor , 1997, The Journal of Biological Chemistry.

[6]  T. Branchek,et al.  Expression Cloning of a Rat Hypothalamic Galanin Receptor Coupled to Phosphoinositide Turnover* , 1997, The Journal of Biological Chemistry.

[7]  E. Heuillet,et al.  The human galanin receptor: ligand-binding and functional characteristics in the Bowes melanoma cell line. , 1994, European journal of pharmacology.

[8]  G. Fisone,et al.  Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues. , 1991, European journal of pharmacology.

[9]  G. Fisone,et al.  Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  G. Fisone,et al.  N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Sankar,et al.  Galanin and epilepsy. , 2010, Experientia supplementum.

[12]  G. Fisone,et al.  Galanin and galanin antagonists: molecular and biochemical perspectives. , 1992, Trends in pharmacological sciences.